A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: Opportunities to improve healthcare quality

Jean L. Raphael, Priya B. Shetty, Hao Liu, Donald H. Mahoney, Brigitta U. Mueller

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background. Transcranial Doppler ultrasound (TCD) has been demonstrated to be a powerful predictor of stroke risk due to sickle cell disease (SCD) in pediatric populations. Little is known about how this healthcare innovation has disseminated into preventive care for SCD. The objective of this study was to determine TCD screening rates and modifiable patient barriers in children with SCD. Procedure. We retrospectively assessed the screening of 207 children with SCD at the Texas Children's Sickle Cell Center over a 3-year period (2004-2006). Demographics, adherence to comprehensive care visits, severity of disease, and distance from the sickle cell center were obtained from computerized medical record databases. Screenings cancelled or missed by patients were extracted from a computerized order entry system. Results. The average yearly screening rate for eligible patients was 45%. The average yearly cancellation rate by patients was 20%. Patient with private insurance were three times more likely to be compliant with ordered screenings than patients with Medicaid (P=0.0077). Patients adherent to hematology comprehensive care visits more likely underwent ordered screenings than those who were not (P=0.0386). When given at least one opportunity per year, providers, on average, ordered TCD screening 74% of the time when it was indicated. Conclusions. Despite evidence that routine screening to assess stroke risk is vital to the preventive care of SCD, implementation of this healthcare technology may be slow to disseminate due to patient and provider related factors.

Original languageEnglish (US)
Pages (from-to)647-651
Number of pages5
JournalPediatric Blood and Cancer
Volume51
Issue number5
DOIs
StatePublished - Nov 1 2008
Externally publishedYes

Fingerprint

Quality of Health Care
Sickle Cell Anemia
Pediatrics
Doppler Ultrasonography
Preventive Medicine
Computerized Medical Records Systems
Stroke
Delivery of Health Care
Medicaid
Hematology
Insurance
Demography
Databases
Technology
Population

Keywords

  • Pediatrics
  • Quality improvement
  • Sickle cell disease
  • Stroke

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center : Opportunities to improve healthcare quality. / Raphael, Jean L.; Shetty, Priya B.; Liu, Hao; Mahoney, Donald H.; Mueller, Brigitta U.

In: Pediatric Blood and Cancer, Vol. 51, No. 5, 01.11.2008, p. 647-651.

Research output: Contribution to journalArticle

Raphael, Jean L. ; Shetty, Priya B. ; Liu, Hao ; Mahoney, Donald H. ; Mueller, Brigitta U. / A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center : Opportunities to improve healthcare quality. In: Pediatric Blood and Cancer. 2008 ; Vol. 51, No. 5. pp. 647-651.
@article{e03890a32bd6479e9c6f52ba79a59887,
title = "A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: Opportunities to improve healthcare quality",
abstract = "Background. Transcranial Doppler ultrasound (TCD) has been demonstrated to be a powerful predictor of stroke risk due to sickle cell disease (SCD) in pediatric populations. Little is known about how this healthcare innovation has disseminated into preventive care for SCD. The objective of this study was to determine TCD screening rates and modifiable patient barriers in children with SCD. Procedure. We retrospectively assessed the screening of 207 children with SCD at the Texas Children's Sickle Cell Center over a 3-year period (2004-2006). Demographics, adherence to comprehensive care visits, severity of disease, and distance from the sickle cell center were obtained from computerized medical record databases. Screenings cancelled or missed by patients were extracted from a computerized order entry system. Results. The average yearly screening rate for eligible patients was 45{\%}. The average yearly cancellation rate by patients was 20{\%}. Patient with private insurance were three times more likely to be compliant with ordered screenings than patients with Medicaid (P=0.0077). Patients adherent to hematology comprehensive care visits more likely underwent ordered screenings than those who were not (P=0.0386). When given at least one opportunity per year, providers, on average, ordered TCD screening 74{\%} of the time when it was indicated. Conclusions. Despite evidence that routine screening to assess stroke risk is vital to the preventive care of SCD, implementation of this healthcare technology may be slow to disseminate due to patient and provider related factors.",
keywords = "Pediatrics, Quality improvement, Sickle cell disease, Stroke",
author = "Raphael, {Jean L.} and Shetty, {Priya B.} and Hao Liu and Mahoney, {Donald H.} and Mueller, {Brigitta U.}",
year = "2008",
month = "11",
day = "1",
doi = "10.1002/pbc.21677",
language = "English (US)",
volume = "51",
pages = "647--651",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center

T2 - Opportunities to improve healthcare quality

AU - Raphael, Jean L.

AU - Shetty, Priya B.

AU - Liu, Hao

AU - Mahoney, Donald H.

AU - Mueller, Brigitta U.

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Background. Transcranial Doppler ultrasound (TCD) has been demonstrated to be a powerful predictor of stroke risk due to sickle cell disease (SCD) in pediatric populations. Little is known about how this healthcare innovation has disseminated into preventive care for SCD. The objective of this study was to determine TCD screening rates and modifiable patient barriers in children with SCD. Procedure. We retrospectively assessed the screening of 207 children with SCD at the Texas Children's Sickle Cell Center over a 3-year period (2004-2006). Demographics, adherence to comprehensive care visits, severity of disease, and distance from the sickle cell center were obtained from computerized medical record databases. Screenings cancelled or missed by patients were extracted from a computerized order entry system. Results. The average yearly screening rate for eligible patients was 45%. The average yearly cancellation rate by patients was 20%. Patient with private insurance were three times more likely to be compliant with ordered screenings than patients with Medicaid (P=0.0077). Patients adherent to hematology comprehensive care visits more likely underwent ordered screenings than those who were not (P=0.0386). When given at least one opportunity per year, providers, on average, ordered TCD screening 74% of the time when it was indicated. Conclusions. Despite evidence that routine screening to assess stroke risk is vital to the preventive care of SCD, implementation of this healthcare technology may be slow to disseminate due to patient and provider related factors.

AB - Background. Transcranial Doppler ultrasound (TCD) has been demonstrated to be a powerful predictor of stroke risk due to sickle cell disease (SCD) in pediatric populations. Little is known about how this healthcare innovation has disseminated into preventive care for SCD. The objective of this study was to determine TCD screening rates and modifiable patient barriers in children with SCD. Procedure. We retrospectively assessed the screening of 207 children with SCD at the Texas Children's Sickle Cell Center over a 3-year period (2004-2006). Demographics, adherence to comprehensive care visits, severity of disease, and distance from the sickle cell center were obtained from computerized medical record databases. Screenings cancelled or missed by patients were extracted from a computerized order entry system. Results. The average yearly screening rate for eligible patients was 45%. The average yearly cancellation rate by patients was 20%. Patient with private insurance were three times more likely to be compliant with ordered screenings than patients with Medicaid (P=0.0077). Patients adherent to hematology comprehensive care visits more likely underwent ordered screenings than those who were not (P=0.0386). When given at least one opportunity per year, providers, on average, ordered TCD screening 74% of the time when it was indicated. Conclusions. Despite evidence that routine screening to assess stroke risk is vital to the preventive care of SCD, implementation of this healthcare technology may be slow to disseminate due to patient and provider related factors.

KW - Pediatrics

KW - Quality improvement

KW - Sickle cell disease

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=52249119860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52249119860&partnerID=8YFLogxK

U2 - 10.1002/pbc.21677

DO - 10.1002/pbc.21677

M3 - Article

C2 - 18623200

AN - SCOPUS:52249119860

VL - 51

SP - 647

EP - 651

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 5

ER -